New therapies for cutaneous T-cell lymphomas

Cutaneous lymphomas belong to the rare diseases. They represent a heterogeneous group with very different clinical symptoms and prognosis. Due to the complexity of the disease, the involvement of a specialized center is recommended. In the following, we present three patients with primary cutaneous T-cell lymphomas (CTCL) from our skin cancer center. Based on these case studies, we would like to describe the multimodal therapy of CTCL, taking into account newly approved drugs for this indication.